Influence of interleukin-2 and interferon-gamma in murine schistosomiasis

Cytokine

Volumn 33, Issue 5, 2006, Pages 281-288

  El Ridi, Rashika ^a   Salem, Rabab ^a   Wagih, Amal ^a   Mahana, Noha ^a   El Demellawy, Maha ^b   Tallima, Hatem ^a  

^a CAIRO UNIVERSITY   (Egypt)

^b Universities and Research centers District   (Egypt)

Author keywords

Interferon gamma; Interleukin 2; Lung stage schistosomula; Plasma lipids; Schistosoma mansoni

Indexed keywords

CHOLESTEROL; CYTOKINE; FATTY ACID; GAMMA INTERFERON; LIPID; MESSENGER RNA; PARASITE ANTIBODY; RECOMBINANT GAMMA INTERFERON; RECOMBINANT INTERLEUKIN 2; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG TREATMENT FAILURE; EXPERIMENTAL INFECTION; EXPERIMENTAL MOUSE; FATTY ACID BLOOD LEVEL; FEMALE; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION REGULATION; GENE REPRESSION; HOST RESISTANCE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOREGULATION; IMMUNOSTIMULATION; INFECTION RESISTANCE; LIPID BLOOD LEVEL; LUNG; LUNG INFECTION; MOUSE; MOUSE STRAIN; NONHUMAN; PARASITOSIS; PREDICTION; PRIORITY JOURNAL; PROTEIN INDUCTION; QUANTITATIVE ANALYSIS; RNA ANALYSIS; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; TH1 CELL; TH2 CELL; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION; WORM; WORM EGG;

ANIMALS; CHOLESTEROL; FATTY ACIDS, NONESTERIFIED; GENE EXPRESSION REGULATION; INTERFERON TYPE II; INTERLEUKIN-2; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; RNA, MESSENGER; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; SPECIES SPECIFICITY; TH1 CELLS; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; MURINAE; SCHISTOSOMA; SCHISTOSOMA MANSONI;

EID: 33646052012     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2006.01.009     Document Type: Article

References (53)

1. Fonseca C.T., Brito C.F.A., Alves J.B., and Oliveira S.C. IL-12 enhances protective immunity engendered by immunization with recombinant 14 kDa Schistosoma mansoni fatty acid-binding protein through an IFN-γ and TNF-α dependent pathway. Vaccine 22 (2004) 503-510
2. Reynolds S.R., Dahl C.E., and Harn D.A. T and B epitope determination and analysis of multiple antigenic peptides for the Schistosoma mansoni experimental vaccine triose-phosphate isomerase. J Immunol 152 (1994) 193-200
3. Ferru I., Georges B., Bossus M., Estaquier J., Delacre M., Harn D.A., et al. Analysis of the immune response elicited by a multiple antigen peptide (MAP) composed of two distinct protective antigens derived from the parasite Schistosoma mansoni. Parasite Immunol 10 (1997) 1-11
4. Wolowczuk I., Auriault C., Gras-Masse H., Vendeville C., Balloul J.-M., Tartar A., et al. Protective immunity in mice vaccinated with the Schistosoma mansoni P-28-1 antigen. J Immunol 142 (1989) 1342-1350
5. Pancre V., Wolowczuk I., Guerret S., Copin M.C., Delanoye A., Capron A., et al. Protective effect of rSm28GST-specific T cells in schistosomiasis: role of gamma interferon. Infect Immun 62 (1994) 3723-3730
6. Tallima H., Montash M., Veprek P., Velek J., Jezek J., and El Ridi R. Differences in immunogenicity and vaccine potential of peptides from Schistosoma mansoni glyceraldehyde 3-phosphate dehydrogenase. Vaccine 21 (2003) 3290-3300
7. El Ridi R., Montash M., and Tallima H. Immunogenicity and vaccine potential of di-peptidic multiple antigen peptides from Schistosoma mansoni glyceraldehyde 3-phosphate dehydrogenase. Scand J Immunol 60 (2004) 392-402
8. Coulson P.S. The radiation-attenuated vaccine against schistosomes in animal models: paradigm for a human vaccine?. Adv Parasitol 39 (1997) 271-336
9. Wynn T.A., and Hoffmann K.F. Defining a schistosomiasis vaccination strategy- Is it really Th1 versus Th2?. Parasitol Today 16 (2000) 497-501
10. Mountford A.P., Hogg K.G., Coulson P.S., and Brombacher F. Signaling via interleukin-4 receptor α-chain is required for successful vaccination against schistosomiasis in BALB/c mice. Infect Immun 69 (2001) 228-236
11. Dean D.A., Mangold B.L., Georgi J.R., and Jacobson R.H. Comparison of Schistosoma mansoni migration patterns in normal and irradiated cercaria-immunized mice by means of autoradiographic analysis. Evidence that worm elimination occurs after the skin phase in immunized mice. Am J Trop Med Hyg 33 (1984) 89-96
12. von Lichtenberg F., Correa-Oliveira R., and Sher A. The fate of challenge schistosomula in the murine anti-schistosome vaccine model. Am J Trop Med Hyg 34 (1985) 96-106
13. Wilson R.A., Coulson P.S., and Dixon B. Migration of the schistosomula of Schistosoma mansoni in mice vaccinated with radiation-attenuated cercariae, and normal mice: an attempt to identify the timing and site of parasite death. Parasitology 92 (1986) 101-106
14. Kassim O.O., Dean D.A., Mangold B.L., and von Lichtenberg F. Combined microautoradiographic and histopathologic analysis of the fate of challenge Schistosoma mansoni schistosomula in mice immunized with irradiated cercariae. Am J Trop Med Hyg 47 (1992) 231-237
15. Dean D.A., and Mangold B.L. Evidence that both normal and immune elimination of Schistosoma mansoni take place at the lung stage of migration prior to parasite death. Am J Trop Med Hyg 47 (1992) 238-248
16. Dean D.A., Mangold B.L., and Lewis F.A. Comparison of two strains of Schistosoma mansoni with respect to the sites and kinetics of immune elimination in irradiated cercaria-immunized mice. J Parasitol 81 (1995) 43-47
17. Smythies L.E., Coulson P.S., and Wilson R.A. Monoclonal antibody to IFN-γ modifies pulmonary inflammatory responses and abrogates immunity to Schistosoma mansoni in mice vaccinated with attenuated cercariae. J Immunol 149 (1992) 3654-3658
18. Wynn T.A., Oswald I.P., Eltoum I.A., Caspar P., Lowenstein C.J., Lewis F.A., et al. Elevated expression of Th1 cytokines and nitric oxide synthase in the lungs of vaccinated mice after challenge infection with Schistosoma mansoni. J Immunol 153 (1994) 5200-5209
19. Jankovic D., Wynn T.A., Kullberg M.C., Hieny S., Caspar P., James S., et al. Optimal vaccination against Schistosoma mansoni requires the induction of both B cell- and IFN-γ-dependent effector mechanisms. J Immunol 162 (1999) 345-351
20. Hoffmann K.F., James S.L., Cheever A.W., and Wynn T.A. Studies with double cytokine-deficient mice reveal that highly polarized Th1- and Th2-type cytokine and antibody responses contribute equally to vaccine-induced immunity to Schistosoma mansoni. J Immunol 163 (1999) 927-938
21. Dean D.A. Decreased binding of cytotoxic antibody by developing Schistosoma mansoni. Evidence for a surface change independent of host antigen adsorption and membrane turnover. J Parasitol 63 (1977) 418-426
22. Dessein A., Samuelson J.C., Butterworth A.E., Hogan M., Sherry B.A., Vadas M.A., et al. Immune evasion by Schistosoma mansoni: loss of susceptibility to antibody or complement-dependent eosinophil attack by schistosomula cultured in medium free of macromolecules. Parasitology 82 (1981) 357-374
23. Foley M., MacGregor A.N., Kusel J.R., Garland P.B., Downie T., and Moore I. The lateral diffusion of lipid probes in the surface membrane of Schistosoma mansoni. J Cell Biol 103 (1986) 807-818
24. Kusel J.R., and Gordon J.F. Biophysical studies of the schistosome surface and their relevance to its properties under immune and drug attack. Parasite Immunol 11 (1989) 431-451
25. El Ridi R., Mohamed S.H., and Tallima H. Incubation of Schistosoma mansoni lung-stage schistosomula in corn oil exposes their surface membrane antigenic specificities. J Parasitol 89 (2003) 1064-1067
26. El Ridi R., Tallima H., Mohamed S.H., and Montash M. Depletion of Schistosoma mansoni lung-stage schistosomula cholesterol by methyl-β-cyclodextrin dramatically increases specific antibody binding to surface membrane antigens. J Parasitol 90 (2004) 727-732
27. Tallima H., and El Ridi R. Methyl-β-cyclodextrin treatment and filipin staining reveal the role of cholesterol in surface membrane antigen sequestration of Schistosoma mansoni and S. haematobium lung-stage larvae. J Parasitol 91 (2005) 720-725
28. Tallima H., Salah M., and El Ridi R. In vitro and in vivo effects of unsaturated fatty acids on Schistosoma mansoni and S. haematobium lung-stage larvae. J Parasitol 91 (2005) 1094-1102
29. Jayadev S., Linardic C.M., and Hannun Y.A. Identification of arachidonic acid as a mediator of sphingomyelin hydrolysis in response to tumor necrosis factor α. J Biol Chem 269 (1994) 5757-5763
30. Redman C.A., Kennington S., Spathopoulou T., and Kuse J.R. Interconversion of sphingomyelin and ceramide in adult Schistosoma mansoni. Mol Biochem Parasitol 90 (1997) 145-153
31. Robinson B.S., Hii C.S., Poulos A., and Ferrante A. Activation of neutral sphingomyelinase in human neutrophils by polyunsaturated fatty acids. Immunology 91 (1997) 274-280
32. Worgall T.S., Johnson R.A., Seo T., Gierens H., and Deckelbaum R.J. Unsaturated fatty acid-mediated decreases in sterol regulatory element-mediated gene transcription are linked to cellular sphingolipid metabolism. J Biol Chem 277 (2002) 3878-3885
33. Liao W., and Floren C.H. Endotoxin, cytokines, and hyperlipidemia. Scand J Gastroenterol 28 (1993) 97-103
34. Hardartottir I., Grunfeld C., and Feingold K.R. Effects of endotoxin and cytokines on lipid metabolism. Curr Opin Lipid 5 (1994) 207-215
35. Grunfeld C., and Feingold K.R. Regulation of lipid metabolism by cytokines during host defense. Nutrition 12 (1996) S24-S26
36. Davenport P., and Tipping P.G. The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice. Am J Pathol 163 (2003) 1117-1125
37. Mallat Z., Gojova A., Brun V., Esposito B., Fournier N., Cottrez F., et al. Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice. Circulation 108 (2003) 1232-1237
38. Smithers S.R., and Terry R.J. The infection of laboratory hosts with cercariae of Schistosoma mansoni and the recovery of the adult worms. Parasitology 55 (1965) 695-700
39. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162 (1987) 156-159
40. Overbergh L., Valckx D., Waer M., and Mathieu C. Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR. Cytokine 11 (1999) 305-312
41. Overbergh L., Giulietti A., Valckx D., Decallonne B., Bouillon R., and Mathieu C. The use of real-time reverse transcriptase PCR for the quantification of cytokine gene expression. J Biomol Tech 14 (2003) 33-43
42. Woodward M.P., Young Jr. W.W., and Bloodgood R.A. Detection of monoclonal antibodies specific for carbohydrate epitopes using periodate oxidation. J Immunol Methods 78 (1985) 143-153
43. Cheever A.W. Relative resistance of the eggs of human schistosomes to digestion in potassium hydroxide. Bull World Hlth Org 43 (1970) 601-603
44. McKerrow J.H. Cytokine induction and exploitation in schistosome infections. Parasitology 115 (1997) S107-S112
45. Pemberton R.M., Smythies L.E., Mountford A.P., and Wilson R.A. Patterns of cytokine production and proliferation by T lymphocytes differ in mice vaccinated or infected with Schistosoma mansoni. Immunology 73 (1991) 327-333
46. Shibuya K., Robinson D., Zonin F., Hartley S.B., Macatonia S.E., Somoza C., et al. IL-1 α and TNF-α are required for IL-12-induced development of Th1 cells producing high levels of IFN-γ in BALB/c but not C57BL/6 mice. J Immunol 160 (1998) 1708-1716
47. Mountford A.P., Hogg K.G., Coulson P.S., and Brombacher F. Signaling via interleukin-4 receptor α chain is required for successful vaccination against schistosomiasis in mice. Infect Immun 69 (2001) 228-236
48. Watanabe H., Numata K., Ito T., Takagi K., and Matsukawa A. Innate immune response in Th1- and Th2-dominant mouse strains. Shock 22 (2004) 460-466
49. El Ridi R., Ragab S., Lewis S., and Afifi A. Role of IgE in primary murine Schistosomiasis mansoni. Scand J Immunol 53 (2001) 24-31
50. Cote-Sierra J., Foucras G., Guo L., Chiodetti L., Young H.A., Hu-Li J., et al. Interleukin 2 plays a central role in Th2 differentiation. Proc Nat Acad Sci USA 101 (2004) 3880-3885
51. Nelson B.H. IL-2, regulatory cells, and tolerance. J Immunol 172 (2004) 3983-3988
52. Schroder K., Hertzog P.J., Ravasi T., and Hume D.A. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 75 (2004) 163-189
53. Wolowczuk I., Delacre M., Roye O., Giannini S.L., and Auriault C. Interleukin-7 in the skin of Schistosoma mansoni-infected mice is associated with a decrease in interferon-gamma production and leads to an aggravation of the disease. Immunology 91 (1997) 35-44